InsiderClue
Stocks · Health care · Pharmaceutical Preparations

KYNTRA BIO, INC.

KYNB Clue Score31
United States Fiscal year ends December CIK 0000921299
$6.11 +2.52% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $6.11 −41.81% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue183.2Operating income−50.0Net income−58.1Fiscal year 2017Revenue131.0 −28.5%Operating income−117.3Net income−120.9Fiscal year 2018Revenue213.0 +62.6%Operating income−86.7Net income−86.4Fiscal year 2019Revenue256.6 +20.5%Operating income−89.3Net income−77.0Fiscal year 2020Revenue176.3 −31.3%Operating income−191.9Net income−189.3EPS, diluted−2.11Fiscal year 2021Revenue235.3 +33.5%Operating income−288.5Net income−290.0EPS, diluted−3.14Fiscal year 2022Revenue140.7 −40.2%Operating income−301.0Net income−293.7EPS, diluted−3.14Fiscal year 2023Revenue46.8 −66.7%Operating income−322.7Net income−284.2EPS, diluted−2.92Fiscal year 2024Revenue29.6 −36.7%Operating income−150.4Net income−47.6EPS, diluted−11.89Fiscal year 2025Revenue6.4 −78.3%Operating income−45.9Net income183.5EPS, diluted45.37
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 183.2 131.0 213.0 256.6 176.3 235.3 140.7 46.8 29.6 6.4
Growth −28.5% +62.6% +20.5% −31.3% +33.5% −40.2% −66.7% −36.7% −78.3%
Operating income −50.0 −117.3 −86.7 −89.3 −191.9 −288.5 −301.0 −322.7 −150.4 −45.9
Net income −58.1 −120.9 −86.4 −77.0 −189.3 −290.0 −293.7 −284.2 −47.6 183.5
Growth
EPS, diluted n/a n/a n/a n/a −2.11 −3.14 −3.14 −2.92 −11.89 45.37

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−27.3%Net margin−31.7%Free cash flow margin3.2%Fiscal year 2017Operating margin−89.5%Net margin−92.3%Free cash flow margin−57.3%Fiscal year 2018Operating margin−40.7%Net margin−40.6%Free cash flow margin−39.5%Fiscal year 2019Operating margin−34.8%Net margin−30.0%Free cash flow margin−32.9%Fiscal year 2020Operating margin−108.8%Net margin−107.4%Free cash flow margin44.0%Fiscal year 2021Operating margin−122.6%Net margin−123.3%Free cash flow margin−37.2%Fiscal year 2022Operating margin−213.9%Net margin−208.7%Free cash flow margin−106.4%Fiscal year 2023Operating margin−689.5%Net margin−607.3%Free cash flow margin−678.5%Fiscal year 2024Operating margin−507.8%Net margin−160.6%Free cash flow margin−466.8%Fiscal year 2025Operating margin−712.7%Net margin2,848.6%Free cash flow margin−74.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −27.3% −89.5% −40.7% −34.8% −108.8% −122.6% −213.9% −689.5% −507.8% −712.7%
Net margin −31.7% −92.3% −40.6% −30.0% −107.4% −123.3% −208.7% −607.3% −160.6% 2,848.6%
Free cash flow margin 3.2% −57.3% −39.5% −32.9% 44.0% −37.2% −106.4% −678.5% −466.8% −74.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow7.1Capital expenditure−1.3Free cash flow5.9Fiscal year 2017Operating cash flow−66.5Capital expenditure−8.5Free cash flow−75.0 −1,381.0%Fiscal year 2018Operating cash flow−76.1Capital expenditure−8.0Free cash flow−84.2Fiscal year 2019Operating cash flow−78.7Capital expenditure−5.8Free cash flow−84.5Fiscal year 2020Operating cash flow81.6Capital expenditure−4.0Free cash flow77.6Fiscal year 2021Operating cash flow−82.2Capital expenditure−5.2Free cash flow−87.4 −212.6%Fiscal year 2022Operating cash flow−145.9Capital expenditure−3.7Free cash flow−149.7Fiscal year 2023Operating cash flow−315.0Capital expenditure−2.5Free cash flow−317.5Fiscal year 2024Operating cash flow−138.0Capital expenditure−0.3Free cash flow−138.3Fiscal year 2025Operating cash flow−4.8Capital expenditure−0.0Free cash flow−4.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 7.1 −66.5 −76.1 −78.7 81.6 −82.2 −145.9 −315.0 −138.0 −4.8
Capital expenditure −1.3 −8.5 −8.0 −5.8 −4.0 −5.2 −3.7 −2.5 −0.3 −0.0
Free cash flow 5.9 −75.0 −84.2 −84.5 77.6 −87.4 −149.7 −317.5 −138.3 −4.8
Growth −1,381.0% −212.6%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash173.8Shareholders’ equity155.8Fiscal year 2017Cash673.7Shareholders’ equity528.5Fiscal year 2018Cash89.3Shareholders’ equity509.2Fiscal year 2019Cash126.3Shareholders’ equity516.1Fiscal year 2020Cash678.4Shareholders’ equity422.2Fiscal year 2021Cash171.2Shareholders’ equity209.1Fiscal year 2022Cash155.7Shareholders’ equity−21.4Fiscal year 2023Cash81.6Shareholders’ equity−204.2Fiscal year 2024Cash50.5Shareholders’ equity−225.6Fiscal year 2025Cash47.9Shareholders’ equity−30.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 173.8 673.7 89.3 126.3 678.4 171.2 155.7 81.6 50.5 47.9
Shareholders’ equity 155.8 528.5 509.2 516.1 422.2 209.1 −21.4 −204.2 −225.6 −30.0

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024† 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
183.2 131.0 213.0 256.6 176.3 235.3 140.7 46.8 29.6 6.4
Growth −28.5% +62.6% +20.5% −31.3% +33.5% −40.2% −66.7% −36.7% −78.3%
n/a n/a n/a 1.1 8.9 12.9 20.3 4.0 15.6 0.6
187.2 196.5 235.8 209.3 252.9 387.0 296.8 266.5 95.7 23.5
46.0 51.8 63.8 135.5 106.4 123.9 124.7 86.5 49.3 27.7
−50.0 −117.3 −86.7 −89.3 −191.9 −288.5 −301.0 −322.7 −150.4 −45.9
Growth
−58.1 −120.6 −86.1 −76.6 −188.7 −290.7 −294.9 −323.2 −153.4 −58.3
−0.1 0.3 0.3 0.3 0.4 0.3 0.4 −0.3 −0.3 −0.1
−58.1 −120.9 −86.4 −77.0 −189.3 −290.0 −293.7 −284.2 −47.6 183.5
Growth
Per share
n/a n/a n/a n/a −2.11 −3.14 −3.14 −2.92 −11.89 45.37
n/a n/a n/a n/a −2.11 −3.14 −3.14 −2.92 −11.89 45.37
Growth
n/a n/a n/a n/a 89.9 92.3 93.6 97.3 4.0 4.0
n/a n/a n/a n/a 89.9 92.3 93.6 97.3 4.0 4.0
Growth +2.8% +1.3% +4.0% −95.9% +1.0%

† The diluted share count jumps at 2024, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue shrank 48.4% a year over five years.
  • Operating margin is down 603.8 points on five years ago, at -712.7%.
  • A net loss in 9 of 10 years on file.